
Serum KLKB1 as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Based on Data-Independent Acquisition and Parallel Reaction Monitoring
Author(s) -
YiQun Che,
Yue Zhang,
Han-Bing Li,
Di Shen,
Wei Cui
Publication year - 2021
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s325629
Subject(s) - hepatocellular carcinoma , medicine , oncology , proportional hazards model , biomarker , cohort , survival analysis , igfbp3 , biology , growth factor , receptor , biochemistry
With the advancement of minimally invasive surgery and catheters for hepatocellular carcinoma (HCC), it is becoming more and more inconvenient to get tissues or the tissues gained are insufficient for testing. Screening of blood-derived markers is of great significance for prognosis assessment.